Inhibition Of Olfactory Neurosensory Function To Treat Eating Disorders And Obesity

Abstract

The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.


Claims
Download PDF
Document Preview
Document History
  • Publication: Nov 21, 2006
  • Application: Feb 18, 2003
    US US 36918803 A
  • Priority: Feb 18, 2003
    US US 36918803 A

Sign in to the Lens

Feedback